For a century, medicine measured lifespan. We measure healthspan — the fraction of your years spent at full cognitive, physical, and emotional capacity. Our instruments do not promise immortality. They return to you the years that inflammation, metabolic drift, and epigenetic noise had quietly withdrawn from your account. The difference is precision, and precision is what a decade of private research finally affords.
In 2016, a single observation upended our working hypothesis: a specific pattern of methylation loss correlates, within ±0.3 years, with every biological marker we had ever measured. Reverse the pattern, and the markers follow.
Our protocol is not a supplement. It is a sequenced, thirty-six-month recalibration of the epigenome — administered in quarterly cycles, monitored by continuous biomarker sampling, and refined by a closed-loop intelligence system.
Ten years of quiet work, four public inflection points. Each year below unlocks on hover; the complete dossier is available upon request.
Whole-genome methylation sequencing across 28,412 CpG sites establishes your personal baseline — the coordinate system for everything that follows.
Three proprietary small-molecule arcs, delivered in precisely spaced twelve-week cycles. No product; a sequence.
Adaptive macro and micronutrient architecture re-tuned every fortnight against your continuous biomarker stream.
Photic, thermal and behavioural sequencing re-anchors your suprachiasmatic clock — the upstream governor of 40% of the genome.
A private inference system ingests your bi-weekly biomarker deltas and returns next-cycle adjustments in 14 minutes, not 14 weeks.
Biological-age read-outs are re-computed by two independent laboratories on a blinded basis. No number in your dossier is ours alone.
What AXIOM gave me was not youth — it was the discovery that I had been operating at 70% for fifteen years without noticing. The return to baseline was, frankly, disorientating. I had to relearn what 'rested' felt like.
I arrived sceptical. I leave with three independent laboratories confirming a 4.8-year reversal. More importantly: my father's cardiovascular trajectory, which I had quietly assumed was my own, has been rewritten.
The protocol is not glamorous. It is quietly, almost tediously rigorous — and that is precisely why it works. Anything that promised more would have warranted my suspicion.
Plates 003–008 · Unpublished · Reproduction restricted under NDA-142.
003 · Microfluidic array
004 ·
Forest observation
005 · Methylation map
006 · Hydrogel culture
007 · Dr. Fontaine
008 · CryostoragePricing reflects the full thirty-six-month cycle, independent laboratory verification, and quarterly on-site consultations. Intake closes on April 19, 2026.
The complete ninety-eight-page dossier — protocol, cohort data, peer reviews, and the private correspondence archive — is delivered to qualified applicants within forty-eight hours.